Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Commercialization Timeline Change

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Feb 17, 2022 5:24pm

430 Views

Post# 34439808

RE:Commercialization Timeline Change

So a 3 year step forward of commercializion timline...

Now do ya'll recall that lil ol pr about the little fda darling being on the phone to daddy FDA.

FDA was like little darling you just call me right up if you want to talk...

Looks like they been chattin it up.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec